HOXA13 antibody (C-Term)
Quick Overview for HOXA13 antibody (C-Term) (ABIN2285144)
Target
See all HOXA13 AntibodiesReactivity
Host
Clonality
Conjugate
Application
- 
    - 
                                            Binding Specificity
- AA 355-383, C-Term
- 
                                            Cross-Reactivity
- Human
- 
                                            Cross-Reactivity (Details)
- Calculated cross reactivity: Hu
- 
                                            Characteristics
- HOXA13, CT (HOXA13, HOX1J, Homeobox protein Hox-A13, Homeobox protein Hox-1J)
- 
                                            Purification
- Purified by Protein A affinity chromatography.
- 
                                            Immunogen
- HOXA13 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 355-383 amino acids from the C-terminal region of human HOXA13.
- 
                                            Isotype
- IgG
 
- 
                                            
- 
    
- 
    - 
                                            Application Notes
- Optimal working conditions should be determined by the investigator.
- 
                                            Restrictions
- For Research Use only
 
- 
                                            
- 
    - 
                                            Format
- Liquid
- 
                                            Buffer
- Supplied as a liquid in PBS, pH 7.2, 0.09 % sodium azide.
- 
                                            Preservative
- Sodium azide
- 
                                            Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 
                                            Storage
- -20 °C
- 
                                            Storage Comment
- -20°C
 
- 
                                            
- 
    
- 
                    
 
                                     
                                     
                                    